Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S N Goldberg
Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts
British Journal of Cancer
Cancer Research
Oncology
Related publications
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy
New England Journal of Medicine
Medicine
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
The Function of COX-2 in Human Ovarian Carcinoma
American Journal of Pathology
Forensic Medicine
Pathology
VEGF-C, VEGFR-3, and COX-2 Enhances Growth and Metastasis of Human Cervical Carcinoma Cell Lines in Vitro
Oncology Reports
Medicine
Cancer Research
Oncology
A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Significance of Cyclooxygenase‑2, Prostaglandin E2 and CD133 Levels in Sunitinib‑resistant Renal Cell Carcinoma
Oncology Letters
Cancer Research
Oncology